US equities |
META $622.61 ▼-1.26% TSLA $405.87 ▲+3.64% MU $931.26 ▲+3.05% NVDA $217.72 ▲+0.79% SPCX $149.62 ▲+1.85% AMD $559.69 ▲+5.35% SNDK $1,296.31 ▲+3.24% AAPL $345.54 ▲+0.47%
FinancialContent

Henryschein Dental Company (NQ:HSIC)

83.91 -0.60 (-0.71%)
Delayed Quote Updated: 2:17 PM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Henryschein Dental Company

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
News headline image
Henry Schein One Unveils the Next Era of Dentrix Ascend for DSOs and Growth-Focused Practices
From Henry Schein One
Via Business Wire
News headline image
3 Cash-Producing Stocks We’re Skeptical Of
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not... 
Via StockStory
News headline image
Henry Schein to Participate in Upcoming Investor Conferences in March
From Henry Schein, Inc.
Via Business Wire
News headline image
BlackLine Stock Down Nearly 30% as One Fund Cuts Stake by $10 Million ↗
BlackLine delivers cloud-based automation tools for enterprise finance teams, serving a global client base with a subscription SaaS model. 
Via The Motley Fool
Topics Regulatory Compliance
Unusual volume S&P500 stocks in Tuesday's session ↗
Via Chartmill
News headline image
Sotera Health Up 30% This Past Year, so Why Did One Fund Sell $4 Million in Shares? ↗
Sotera Health delivers sterilization and laboratory solutions to healthcare, pharmaceutical, and food industry clients worldwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Profitable Stocks We Approach with Caution
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
News headline image
Henry Schein (HSIC) Stock Trades Up, Here Is Why
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) jumped 4.8% in the afternoon session after the company reported decent fourth-quarter 2025 financial results where revenue... 
Via StockStory
Topics Artificial Intelligence Earnings Supply Chain
Henry Schein Inc (NASDAQ:HSIC) Reports Strong Q4 Earnings Beat and Steady 2026 Outlook ↗
Via Chartmill
Topics Earnings
Henry Schein Inc (NASDAQ:HSIC) Shows Strong Technical Setup for Potential Breakout ↗
Via Chartmill
Top S&P500 movers in Tuesday's session ↗
Via Chartmill
News headline image
Henry Schein (HSIC) Q4 2025 Earnings Transcript ↗
Henry Schein (HSIC) Q4 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Henry Schein’s (NASDAQ:HSIC) Q4 CY2025 Sales Beat Estimates
Dental and medical products company Henry Schein (NASDAQ:HSIC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.7% year on year to $3.44 billion. Its GAAP profit... 
Via StockStory
Topics Earnings
News headline image
Henry Schein Reports Fourth Quarter and Full Year 2025 Financial Results and Introduces 2026 Financial Guidance
From Henry Schein, Inc.
Via Business Wire
News headline image
Earnings To Watch: Henry Schein (HSIC) Reports Q4 Results Tomorrow
Dental and medical products company Henry Schein (NASDAQ:HSIC) will be reporting results this Tuesday morning. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
Henry Schein One Launches Image Verify, Another Transformative Step Towards Achieving the Cleanest Claims in the Industry
From Henry Schein One
Via Business Wire
News headline image
Henry Schein One Connects Align Technology’s iTero™ Scanners to Dentrix, Dentrix Ascend, and Dentally, Advancing a More Connected Global Standard of Care
From Henry Schein One
Via Business Wire
News headline image
1 Safe-and-Steady Stock with Solid Fundamentals and 2 That Underwhelm
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program
From Henry Schein, Inc.
Via Business Wire
News headline image
3 Value Stocks That Fall Short
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
News headline image
1 S&P 500 Stock on Our Buy List and 2 That Underwhelm
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
News headline image
Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET
From Henry Schein, Inc.
Via Business Wire
News headline image
3 Reasons to Sell HSIC and 1 Stock to Buy Instead
Henry Schein trades at $76.27 per share and has stayed right on track with the overall market, gaining 8% over the last six months. At the same time, the S&P 500 has returned 11.5%. 
Via StockStory
Topics Stocks
News headline image
Henry Schein Names Frederick M. Lowery as Chief Executive Officer
From Henry Schein, Inc.
Via Business Wire
Tuesday's pre-market session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
Dental Equipment & Technology Q3 Earnings: Envista (NYSE:NVST) Simply the Best
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Envista (NYSE:NVST) and its peers. 
Via StockStory
News headline image
One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan ↗
An improving earnings profile, aggressive buybacks, and a renewed focus on margins might be changing how long-term investors think about this healthcare distributor. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Henry Schein to Participate in the J.P. Morgan Conference in January
From Henry Schein, Inc.
Via Business Wire
News headline image
Henry Schein Provides Update on CEO Search Process
From Henry Schein, Inc.
Via Business Wire
News headline image
Medline’s Blockbuster IPO Ignites Market Optimism: The Largest Debut Since 2021
In a stunning return to the public stage, Medline Industries (Nasdaq: MDLN) successfully executed the largest initial public offering (IPO) in the United States since 2021, pricing its shares at the... 
Via MarketMinute
Topics Economy Initial Public Offering World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >